New York State Teachers Retirement System Lowers Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

New York State Teachers Retirement System lowered its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 360,377 shares of the company’s stock after selling 2,002 shares during the period. New York State Teachers Retirement System owned 0.08% of GE HealthCare Technologies worth $28,174,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. LGT Financial Advisors LLC grew its holdings in shares of GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares in the last quarter. Ashton Thomas Securities LLC bought a new stake in GE HealthCare Technologies during the third quarter valued at approximately $26,000. Capital Performance Advisors LLP purchased a new position in GE HealthCare Technologies in the 3rd quarter worth approximately $26,000. Darwin Wealth Management LLC bought a new position in shares of GE HealthCare Technologies in the 3rd quarter worth $31,000. Finally, Continuum Advisory LLC raised its position in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after buying an additional 168 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 1.4 %

Shares of NASDAQ GEHC opened at $92.21 on Friday. The company has a market cap of $42.13 billion, a price-to-earnings ratio of 25.33, a PEG ratio of 2.93 and a beta of 1.15. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The firm’s fifty day moving average is $84.03 and its 200 day moving average is $85.53. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. On average, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th were given a $0.035 dividend. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.15%. The ex-dividend date of this dividend was Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

Analysts Set New Price Targets

GEHC has been the topic of a number of research analyst reports. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday. Finally, Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.